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ABSTRACT
Congenital anomalies of the kidneys or lower urinary tract (CAKUT) are the most common causes of renal failure in
children and account for 25% of end-stage renal disease in adults. The spectrum of anomalies includes renal agenesis;
hypoplasia; dysplasia; supernumerary, ectopic or fused kidneys; duplication; ureteropelvic junction obstruction; primary
megaureter or ureterovesical junction obstruction; vesicoureteral reflux; ureterocele; and posterior urethral valves. CAKUT
originates from developmental defects and can occur in isolation or as part of other syndromes. In recent decades, along
with better understanding of the pathological features of the human congenital urinary tract defects, researchers using
animal models have provided valuable insights into the pathogenesis of these diseases. However, the genetic causes and
etiology of many CAKUT cases remain unknown, presenting challenges in finding effective treatment. Here we provide an
overview of the critical steps of normal development of the urinary system, followed by a description of the pathological
features of major types of CAKUT with respect to developmental mechanisms of their etiology.
Keywords: CAKUT, congenital, development, genetics, kidney, urinary tract

INTRODUCTION
The functioning unit of the kidney that produces urine is called
the nephron. For the purpose of this article, the proximal nephron comprises the glomerulus, proximal tubules, loop of Henle
and distal tubules. The distal nephron harbors the collecting
system, mainly consisting of the collecting ducts. The filtrate,
namely urine, from the kidney is passed to the lower urinary
tract (ureter, bladder and urethra) for expulsion. Development
of the urinary system is a highly complex process that depends
on precise spatiotemporally regulated events and requires the
integration of a variety of progenitor cell populations of different embryonic origins [1–3]. These events culminate in precise
anatomical connections between the proximal and distal nephrons in the kidney (upper tract) and the upper and lower urinary

tract. Most clinically relevant congenital anomalies of the kidneys or lower urinary tract (CAKUT) originate from the disruption of regulatory circuitry and the progenitor cells involved in
these processes, especially in the morphogenesis of the urinary
conduit or the functional aspects of the pyeloureteral peristaltic
machinery. The power of genetics and molecular biology in
model organisms has greatly advanced our knowledge that is
directly relevant to CAKUT in humans [4–9]. In this review we
will provide an overview of the major steps in nephrogenesis
and the development of the lower urinary tract. We will then
describe the pathological features of major types of CAKUT and
discuss the developmental pathology leading to CAKUT, based
on the evidence from human patients and animal disease models, especially murine models.
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NORMAL DEVELOPMENT OF THE KIDNEYS
AND THE URINARY TRACT

Preureteric bud induction and Wolffian duct
morphogenesis
Most components of the urinary system are derived from the intermediate mesoderm [12] that give rise to the nephrogenic
cords at about 3 weeks of gestation (wg) in humans and about
embryonic day 8 (E8) in mice. The nephrogenic cord produces
three sets of nephric structures: pronephros, mesonephros and
metanephros (Figure 1). Pronephros is the cranial most transient structure that emerges at about 3 wg in humans and
regresses by 4 wg (E9.5 in mice). Mesonephros development
coincides with pronephros regression and caudal extension of
the nephrogenic cord that metamorphoses into the mesonephric duct (Wolffian duct) and is surrounded by mesonephric mesenchyme. In mammals, the mesonephros is transient but
functional. In humans, the mesonephric tubules are linearly arranged along the Wolffian duct and are directly connected to it
(Figure 2). The Wolffian duct joins the cloaca (future bladder),
initiating the connection between the upper and lower urinary
tracts. In humans, the mesonephros regresses by 16 wg in a
caudal-to-cranial manner (by E11.5 in mice) except in males,
where the cranial most mesonephric tubules become the epididymis and efferent ductules and the Wolffian duct becomes
the vas deferens. The precise regression of the mesonephroi is
critical for normal kidney development, and this process is regulated by signals in the Wolffian duct [13].

FIGURE 1: Illustration shows events in mammalian kidney development using
mouse stages as an example. Pronephros, the first stage, begins at about embryonic day 8 (E8) from intermediate cells. Mesonephros includes mesonephric
mesenchyme (MesM) and an epithelial tube called the Wolffian duct (WD). By
E10.5, the Wolffian duct has inserted into the cloaca, MesM is degenerating and
a bulge on the distal aspect of the WD develops into the UB that grows toward
the MM. The portion of the Wolffian duct distal to the UB is called the common
nephric duct (CND). At E11.5, the UB invades the MM, causing certain cells in the
MM to coalesce around the UB tips. These are called cap mesenchyme cells
(CaPM). Interactions between CaPM and UB and other cells in the MM initiate recursive branching called branching morphogenesis. At E12.5, the ureter remodeling process starts to insert into the primitive bladder (UGS) and separate from
the Wolffian duct through a process of CND apoptosis (yellow).

Ureteric bud induction
Metanephroi (definitive kidney) begin to form at 4.5 wg (and become functional at 10 wg) in humans and E10.5 in mice.
Metanephric development starts with the outgrowth of epithelial cells called the ureteric bud (UB) from the caudal Wolffian
duct. The UB invasion of the metanephric mesenchyme (MM),
in response to inductive signals from the MM, induces MM cells
to aggregate around the UB tip. This leads to branching of the
tip to form a T–shaped structure. The MM cells coalesce around
the branched tips to form the cap mesenchyme here after referred to as nephron progenitors. The UB tip cells are the precursors of the collecting ducts. This entire process is called UB
induction and indispensable for kidney formation. Thereafter
the UB undergoes repetitive branching to form the elaborate
collecting duct system through branching morphogenesis.

Branching morphogenesis
Branching morphogenesis requires reciprocal interactions among
the UB, MM, stromal cells and endothelial cells. UB tips proliferate
and branch to give rise to new UBs. The first few branches give rise
to the major and minor calyces in humans, into which the collecting ducts from the respective papillae drain. All major calyces
drain into the pelvis, finally leading into the ureter. Branching
problems can cause decreased kidney mass (hypoplasia) and defective structures (dysplasia). Nephrogenesis begins when mesenchyme cells coalesce near the junction of the UB stalk and the UB

FIGURE 2: Hematoxylin and eosin–stained section from a human fetus during
the mesonephros stage. Note the linearly arranged primitive glomeruli (arrows).

tips and transition into pretubular aggregates. These cells undergo
a series of morphogenetic stages to form the proximal nephron,
consisting of the glomerulus, the proximal tubules, descending
and ascending loops of Henle, distal tubules and connecting
tubules. The endothelial progenitors invade the cleft at the distal
aspect of the S-shaped body along with the stromal cells to
become the glomerular capillaries and mesangium, respectively
[14–16]. Since the kidney grows in a centrifugal manner, the oldest
glomeruli are toward the cortico-medullary junction and the newest ones toward the periphery. Nephrogenesis completes before
birth in humans, but persists in early postnatal days in rodents. At
the end, the human kidney has multiple lobes, each comprising
the cortex, medulla and papillae that drain into minor and major
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Development of the urinary system occurs in several stages in
mammals, culminating in a kidney and a ureter from each half
of the body, which are connected to the bladder. For simplicity
and to correlate the pathogenesis of CAKUT with specific developmental processes, we categorize the development of the kidney and the urinary tract into the following stages [10, 11].
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PATHOLOGICAL AND CLINICAL FEATURES OF
CONGENITAL KIDNEY AND LOWER URINARY
TRACT DEFECTS

FIGURE 3: Hematoxylin and eosin–stained section of human perinatal kidney at
low power shows organization into lobules (appear as bumps) with outer cortex
(darker colored outer layer), medulla and papillae that drain into calyces (crescent-shaped white spaces).

calyces (Figure 3); mice have a single papilla that drains into the
pelvis. The peristaltic activity to propulse urine through the ureter
is initiated from pacemaker cells in the tips of the papillae.

Ascent and rotation
Concurrent to nephrogenesis, kidneys also undergo repositioning through ascent and rotation. The kidneys grow posteriorly
(towards the back) during initial development. As development
progresses, they rotate anteromedially such that each hilum
points medially. Meanwhile, there is apparent ascent due to disproportionate growth of the caudal regions of the embryo such
that the final position of the kidneys is retroperitoneal in the abdomen by 9 wg. The blood supply to the developing kidney is
initially via the caudal segments of the descending aorta or its
iliac branches. As the kidneys ascend, the blood supply is derived from more cranial branches of the aorta while the caudal
vascular connections degenerate. The failure of regression of
transient blood vessels or sprouting of additional vessels to ensure adequate perfusion of the kidney may account for the variability seen in vascular supply to the kidney and accessory
renal arteries. In some cases, failure of regression of transient
vessels may compress the ureters, leading to hydronephrosis.
Ascent and rotation defects can also result in fusion or ectopic
kidneys.

Ureter maturation and bladder–urethra development
The initial stalk of the UB remains outside the MM, matures
into a ureter, elongates and connects to the bladder [10, 17, 18].
Common nephric duct is the part of the Wolffian duct distal to
the point where the ureter is initially attached to the Wolffian
duct (Figure 1). The initial Wolffian duct–cloaca contact occurs
before UB induction. After UB induction, the ureter separates
from the Wolffian duct through a process of ureteral remodeling
and maturation that leads to insertion of ureter into the bladder, the formation of a single lumen and separation of the
Wolffian duct from the ureter. The Wolffian duct inserts in the
urethra in males and degenerates in females. Ureteral smooth
muscle differentiation within the ureteral mesenchyme commences at E14.5 in mice, following the establishment of a connection between the Wolffian duct and bladder epithelium,

CAKUT is a term used broadly to describe developmental
defects in the urinary system that can occur in isolation, in
combination or as part of other syndromes. CAKUT comprises a
wide spectrum of congenital defects in the urinary system,
ranging from renal agenesis and hypoplasia, structural duplication and mispositioning to defects in the ureter and bladder.
Genetic, epigenetic and environmental factors can all cause
these abnormalities. The biology of CAKUT is further complicated by the fact that affected family members may exhibit different types of CAKUT [7, 8, 24–29]. We will discuss the
clinicopathological features of the most common types of
CAKUT in relation to underlying developmental defects and
provide a summary of candidate genes, underlying CAKUT and
the likely developmental mechanisms contributing to the
CAKUT phenotype (Tables 1–3).

Duplication and supernumerary kidneys
In supernumerary kidneys, multiple UBs emerge separately and
grow into the MM [162, 163]. Partial duplication, often clinically
insignificant, can result from UB stalk bifurcation before invading the MM or prior to initial branching of the primary UB stalk
in the MM. In complete duplication, two UBs emerge from the
WD, resulting in two complete sets of kidneys and ureters that
may insert into the bladder separately (Figure 4). These kidneys
may appear fused due to their development in the same MM. In
>95% of such cases, the lower ureter will enter the bladder at its
normal location but tunnels through it abnormally, leading to
reflux [164]. The upper ureter inserts more distally, closer to the
reproductive tract or in the urethra and frequently results in an
ureterocele. The ureterocele often drains the upper kidney or
the upper pole of a duplex kidney. Due to obstruction or reflux,
both kidneys may show dysplasia or obstructive nephropathy.
These patients may present with hypertension, pain and kidney
failure. The incidence of duplication in a clinical setting is 1 in
125 and may be as high as 1 in 25 in postmortem cases [162].
The extra UBs could result from enhanced UB budding signals,
failure to repress extraneous budding or aborted regression of
mesonephric mesenchyme. For reasons still unknown, duplication is more common in women than in men (2:1) [162].

Agenesis
Failure of the kidneys to develop (agenesis) is frequently caused
by defective/delayed WD growth or UB induction. Renal agenesis can be unilateral (1/1000) or bilateral (1/10 000) [165]. Bilateral
agenesis is incompatible with life and is more common in males
[165]. During embryogenesis, kidney agenesis causes oligohydramnios and abnormal lung development. Oligohydramnios or
ahydramnios during fetal development often presents as
Potters sequence: flat facial features, wide-set eyes, limb
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with the appearance of the first wave of a smooth muscle actin–
positive cells [19]. In humans, ureteral muscularization and development of elastic fibers start at 12 wg [20–23]. Bladder epithelium originates from the cloaca, a hindgut derivative with an
endodermal origin, in contrast to the mesodermal origin of the
kidney and the ureter epithelium from the Wolffian duct. Male
urethra develops as the urogenital sinus extends to the surface
of the genital tubercle.
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Table 1. Summary of cause and treatment of lower urinary tract defects affecting kidney function

Defects

Definition

Etiology

Clinical presentation and
pathological features

Diagnosis

Endoscopic valve ablation

Pyeloplasty—open or
laparoscopic

Ureteral reimplantation
with or without a megaureter repair
Ureterocele incision or
excision

Observation versus surgical
repair (endoscopic injection or ureteral
reimplantation)

HN, hydronephrosis; HUN, hydroureteronephrosis; BOO, bladder outlet obstruction; US, ultrasound.

defects, prominent epicanthal folds, hypoplastic lungs and absent to malformed kidneys [166]. Isolated unilateral agenesis
may cause compensatory hypertrophy of the contralateral kidney and is commonly detected during routine sonography
examinations. The incidence is equal in males and females but
higher on the left than on the right side. About 50–70% of unilateral agenesis may exhibit other urogenital anomalies, including
dysplasia, ectopia, reflux and proteinuria, and may present with
hypertension. The term ‘solitary kidney’ is frequently used to
describe the absence of one kidney in living patients. Without
the advantage of serial radiological follow-up from early gestation, it is difficult to determine if agenesis in these patients is
due to complete lack of UB induction or due to involution of a
dysplastic kidney.

Hypoplasia
Hypoplasia refers to small kidneys with a decreased number of
nephrons due to reduced branching morphogenesis. These kidneys exhibit preserved architecture with normal organization into
cortex and medulla. Unilateral hypoplasia has an incidence of 1/
1000, whereas bilateral cases are less frequent (1/4000). Most
patients with bilateral hypoplasia develop end-stage renal disease
(ESRD) in mid or late childhood and have a higher probability of
developing hypertension [165]. Simple unilateral hypoplasia may
have no consequence. Hypoplasia may accompany renal artery
hypoplasia. Macroscopically they may exhibit oligomeganephronia, decreased renal lobes and secondary glomerulosclerosis.

Dysplasia
Dysplastic kidneys have abnormal architectural organization,
immature nephrons, undifferentiated stroma and incomplete
branching [167]. The signaling cues orchestrating nephrogenesis
appear asynchronous and there is a loss of coordinated reciprocal interactions among the UB, MM and stroma during branching morphogenesis. Dysplastic kidneys can be small, normal in
size or slightly larger than healthy kidneys and may show cystic
changes. Dysplasia can be unilateral (1/4300 in multicystic

dysplastic kidneys and 1/1000 in dysplastic kidneys) or bilateral
(1/7500) [165, 167]. Bilateral dysplasia is incompatible with life.
Although definitive diagnosis of dysplasia requires histological
assessment, the clinical diagnosis is often made through antenatal ultrasound. Dysplasia can occur in a portion or the entire
kidney. Contralateral kidney defects may be as high as 50–70%
in patients with unilateral kidney dysplasia who may also have
other CAKUT phenotypes. The prognosis of unilateral dysplasia
is usually good if infections and hypertension are well managed. Extreme forms of dysplasia or arrest in branching can result in involution of the kidney or rudiments, also known as
aplastic kidneys. Extremely aplastic kidneys may be undetectable on radiological exam, leading to the diagnoses of solitary
kidney or unilateral agenesis [168]. Microscopically the dysplastic kidneys show blastema elements; fetal glomeruli; tubular,
glomerular or collecting duct cysts; smooth muscle collarettes
surrounding primitive collecting ducts and cartilage in 30% of
cases (Figure 5). Multicystic dysplasia is a form of abnormal
metanephric differentiation characterized by the presence of renal cysts of varying size and the absence of a normal pelvicaliceal system. Multicystic dysplastic kidneys may persist without
noticeable change, increase in size or undergo spontaneous involution [169–174]. Dysplasia can be caused by primary defects
in branching morphogenesis or secondary to reflux.

Position defects (horseshoe kidneys, renal ectopia and
malrotation)
Position defects occur when kidneys are displaced along the anterior–posterior axis in the abdomen or mediolaterally relative
to their normal location from the midline. Fusion or apposition
of the growing kidneys may occur with position defects and
may become clinically significant when there are associated
anomalies such as refluxing ureters emanating from the fused
kidneys leading to reflux nephropathy (RN). Most fusions occur
near the posterior end of the kidneys. The ascent of the fused
kidneys may be hindered by crossing blood vessels and other
tissues. Thus the fused kidneys may position lower than normal
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Posterior urethral Obstructing valve
Urogenital sinus and Bilateral HN; VUR; spectrum VCUG
valves
leaflets at the postrigone
of renal demise; UTI
terior urethra
malformation
Renal US; diuretic reHigh-grade HN (pre- or
UPJ obstruction
Ureteral obstruction Atretic, narrow or
nal scan; magnetic
postnatal); UTI; flank
aperistatic proxiat the ureteropelresonance
pain
mal ureteral
vic junction
urography
segment
UVJO
Ureteral obstruction Atretic, narrow or
High-grade HUN (pre- or
Renal US; Diuretic
at the UVJ
aperistatic distal
postnatal); UTI; flank
renal scan; magureteral segment
pain
netic resonance
urography
Ureterocele
Balloon dilation of
Ureteral and urogen- Ectopic location may result Renal US; diuretic rethe distal ureter
ital sinus
in BOO; often associated
nal scan; VCUG;
malformation
with complete ureteral
magnetic resoduplication
nance urography
VUR
Vesicoureteral reflux Ureteral and urogen- Pre- or post-natal HN; feVCUG
ital sinus
brile UTI
malformation

Current treatment
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Table 2. A subset of genetic factors involved in CAKUT and the suspected mechanism based largely on the study of animal models
Gene/allele
symbols

Gene names and functions

Defects in human patients and animal models
/

Angiotensin-converting enzyme (enzyme-converting angiotensin I
to angiotensin II)

mice: hydronephrosis, renal
Ace
parenchymal atrophy

Adamts1

A disintegrin-like and metallopeptidase with thrombospondin type 1
motif, 1 (metallopeptidase)
Angiotensinogen (precursor of the
peptide hormone angiotensin)
Angiotensin II receptor, type 1 (1a and
b) (G protein-coupled receptor)

Adamts1/ mice: UPJO, hydronephrosis, hydroureter, other
urogenital defects
Agt/ mice: hydronephrosis, renal
parenchymal atrophy
Agtr1/ (1a and b) mice: partial
penetrance, hydronephrosis in
older mutants, renal parenchymal atrophy
Agtr2/ mice: limited incidence of
hydronephrosis, megaureter, renal parenchymal atrophy
Aldh1a2/ mice rescued by maternal retinoic acid: hydroureter
and hydronephrosis

Agt
Agtr1a/b

Agtr2

Angiotensin II receptor, type 2 (G protein-coupled receptor)

Aldh1a2

Aldehyde dehydrogenase family 1
member A2 (encodes Raldh2, an
enzyme in retinoic acid
synthesis)
Aquaporin 2 (water channel)

Aqp2

b-catenin

BMP4/Bmp4

Bmp5

Bmp7

Bmpr1a

CHRM3/
Chrom3

Dlgh1

Emx2

EYA1/Eya1

Same as Ctnnb1 (adherens junction
protein, involved in Wnt
signaling)
Bone morphogenetic protein 4 (ligand
in the TGF-b superfamily)

References

Defective pyeloureteral peristalsis [19]
as a result of a ureter differentiation defect, a urine concentration defect/polyuria or both
Unclear. Excessive collagen deposit [30]
was found at UPJ
Defective pyeloureteral peristalsis

[31, 32]

Urinary SMC developmental.
[33, 34]
Defect, renal pelvis development

Ectopic and duplicated UB

[24, 35]

Defects in ureter maturation, espe- [36]
cially the insertion of the ureter
into the bladder

Polyuria overwhelms the pyeloure- [37–39]
The cph mutants (Aqp2S256L/S256L)
teral peristaltic machinery
have polyuria and hydronephrosis. Other Aqp2 mutations also
cause renal damage resembling
obstructive nephropathy
Hoxb7-CreT/þ; b-catenin flox/flox mice: Ectopic and supernumerary UB
[40]
hydroureter and hydronephrosis

Ectopic and supernumerary UB
BMP4 mutations found in human
patients with anomalous kidney
development. Bmp4þ/ mice:
hydronephrosis, hydroureter,
other urinary tract defects
Bone morphogenetic protein 5 (Ligand Short ear (Bmp5/) mice have
Spatial constraints in the lower abin the TGF-b superfamily)
hydroureter and hydronephrosis
dominal cavity affect urinary
transfer
MM differentiation and growth
Bone morphogenetic protein 7 (Ligand Renal dysplasia, hypoplasia,
in the TGF-b superfamily)
hydronephrosis and other
defects are seen in mice deficient for Bmp7
Bone morphogenetic protein receptor,
Mice deficient for Bmpr1a in the UB Defective BMP signaling in progenitor populations
type IA (serine/threonine–protein
or the intermediate mesoderm
has renal dysplasia, hypoplasia
kinase receptor)
and other defects
Defective detrusor contraction.
Cholinergic receptor, Muscarinic 3 (G
A frameshift mutation found in
Present in renal epithelia and
protein-coupled receptor)
CHRM3 in familial congenital
bladder muscle with unknown
bladder malformation associfunctions
ated with prune belly-like syndrome. Bladder distension in
Chrom3 mutant mice, especially
in males
Same as Dlg1, Disk-large homolog 1
Dlgh1/ mice: prenatal hydroSM differentiation defect, ectopic
(scaffolding protein)
nephrosis, short ureter and
UB
defects in the ureteral insertion
into the bladder
Defective of UB branching after it
Empty spiracles homeobox 2 (tranMice deficient for Emx2 lack kidinvades MM
scription factor)
ney, ureter, gonads and genital
tracts
Eyes absent homolog 1 (transcription Rare mutation in EYA1 found in
Absence or reduced Gdnf and six
factor)
CAKUT patients. Eya/ mice:
expression
kidney agenesis

[41–43]

[44, 45]

[46, 47]

[48, 49]

[50, 51]

[52, 53]

[54]

[55, 56]

(continued)
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Table 2. (continued)
Gene/allele
symbols

Gene names and functions
Ets variants 4 and 5 (transcription
factors)

Fcgr2b and
Pdcd1

Fc receptor, IgG, low affinity IIb and
programmed cell death 1 (cell surface membrane protein of the
immunoglobulin superfamily)
Fibroblast growth factor (secreted
signaling protein)

Fgf8

Fgfr2
Foxc1 and c2

Fibroblast growth factor receptor 2
(receptor tyrosine kinase)
Forkhead box protein C1/C2 (transcription factor)

Etv4/; Etv5þ/ mice: kidney agenesis and severe hypodisplasia.
Double homozygotes: complete
agenesis
Some Fcgr2b/; Pdcd1/ mice:
hydronephrosis

Mice with MM-specific inactivation
of Fgf8 have renal agenesis and
hypoplasia
Some Pax3-CreT/þ; Fgfr2flox/flox mice
have hydroureter
Foxc1/ and Foxc1þ/, Foxc2þ/
mice: duplex kidney, ureter duplication, hydroureter,
hydronephrosis
Foxd1/ mice: kidney hypoplasia,
fusion, malrotation

Foxd1

Forkhead box D1 (transcription
factor)

FRAS1/Fras1

Fraser syndrome 1 (extracellular ma- Mice deficient for Fras1 have renal
trix protein)
agenesis
Mutations in FREM2 found in
FRAS1-related extracellular matrix
CAKUT patients
protein 2 (extracellular matrix
protein)
GATA-binding protein 2 (transcripGata2/ mice (with YAC rescue of
tion factor)
hematopoietic defects): hydroureter, hydronephrosis
GATA-binding protein 3 (transcripGATA3 mutations found in HDR
tion factor)
(hypoparathyroidism, sensorineural deafness, renal anomaly)
syndrome. Gata3/ mice have
kidney agenesis
Glial cell-derived neurotrophic factor
Mice deficient for Gdnf have renal
(ligand for RET)
agenesis
Mice deficient for Gfra1 have renal
GDNF family receptor a1 (glycosylagenesis. Deletion of Gfra1 after
phosphatidylinositol (GPI)UB induction causes renal
linked cell surface receptor for
hypoplasia
GDNF)
Glioma-associated oncogene family
Mice deficient for Gli3 have renal
zinc finger 3 (transcription factor)
agenesis or malformed kidneys
Gremlin 1 (extracellular BMP
Mice deficient for Grem1 have renal
antagonist)
agenesis
Hepatocyte nuclear factor 1-b (tranHnf1b mutant mice have severe
scription factor)
hypoplasia and other kidney
defects

FREM2

Gata2

GATA3/Gata3

GDNF/Gdnf
GFRA1/Gfra1

Gli3
Grem1
HNF1b/Hnf1b

Hoxa11, Hoxc11
and Hoxd11

Homeobox a11, c11 and d11 (transcription factors)

Hoxa13 and
Hoxd13

Homeobox a13 and d13 (transcription factors)

HPSE2

Heparanase 2 (enzyme that
degrades heparin sulfate
proteoglycans)

Likely mechanism

References

Absence of Etv4 and 5 functions
downstream of Ret to promote
and control branching

[57]

Autoimmune against UPKIIIA

[58]

Defective MM differentiation

[59, 60]

Supernumerary UB, abnormal ureter connection
Ectopic and supernumerary UB

[61]

Altered signaling in the stroma.
Disruption of a key role for renal
capsule during kidney
development
Failure of UB to invade MM

[62]

[63, 64]

[65, 66]

Likely similar to FRAS1/Fras1
mutations

[65]

Unclear

[67]

Defects in nephric duct extension

[68, 69]

UB induction defect

[70–72]

Defects in UB growth and branching morphogenesis

[73]

Defective expression of key kidney
patterning genes
Excessive BMP signaling. Defects in
UB outgrowth
Broad expression in developing
kidney and urinary tract. May affect multiple processes, especially UB outgrowth and
branching
UB induction defect and branching
morphogenesis defects

[74, 75]

Mice with different combination of
mutations in these genes have
various kidney and urinary tract
defects, including hypoplasia
and agenesis
Hoxa13þ/; Hoxd13/ mice: UVJO,
Patterning defects. May have homeotic transformation
hydronephrosis, hydroureter,
other urogenital defects
Mutations in HPSE2 cause urofacial Likely defects in the nerves consyndrome
trolling urinary voiding

[76, 77]
[55, 78–83]

[84–86]

[87]

[88, 89]

(continued)
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Table 2. (continued)
Gene/allele
symbols
Hspa4l

IL-9
Kcnj1

Isl1

L1cam
Lim1

Limp-2 (Lgp85)

Mdm2
NFIA/Nfia

Osr1
PAX2/Pax2

Pbx1

Ppp3r1

Ptprs and Ptprf

Rara and Rarb2

Renin

RET/Ret

Defects in human patients and animal models

Some Hspa4l/ mice have genetic
background-dependent
hydronephrosis
Inhibitor of DNA binding 2
Id2/ and Id2þ/ mice have
hydronephrosis
Interleukin 9 (cytokine)
Overexpressing IL-9 by its own promoter in mice: hydronephrosis
Potassium inwardly rectifying channel, Romk/ mice: hydronephrosis, water and electrolyte balance
subfamily J, member 1 also known
problem
as Romk (ion channel)
Islet1 (transcription factor)
Hoxb6-CreT/þ; Isl1flox/flox mice have
kidney agenesis, hypoplasia and
hydroureter
L1 cell adhesion molecule (transcripL1cam/ mice: hydroureter and
tion factor)
hydronephrosis
Same as Lhx1 – Lim homeobox proHoxb7-CreT/þ; Lim1lz/flox mice (with
Lim1 deletion in the UB derivatein 1 (transmembrane protein)
tives): hydroureter and hydronephrosis. Mice carrying
homozygous germline mutations for Lim1 have renal
agenesis
Same as Scarb2 (scavenger
Limp-2/ mice: kidney and ureter
receptor)
duplication, UPJO, hydroureter
and hydronephrosis
Murine double minute-2 (nuclear
Mice deficient for Mdm2 in the UB
phosphoprotein that binds p53)
develop renal hypoplasia
Nuclear factor I/A (transcription
Nfiaþ/ and Nfia/ mice: vesifactor)
coureteral reflux, hydronephrosis and hydroureter. Human
NFIAþ/ patients have similar
defects
Odd-skipped related 1 (transcription Mice deficient for Osr1 have comfactor)
plete renal agenesis
Paired box gene 2 (transcription
Pax21Neu/þ mice: vesicoureteral
reflux. Other mutant alleles
factor)
also cause vesicoureteral
reflux in addition to renal
agenesis
Pre-B-cell leukemia homeobox 1 (tran- Kidney mispositioning, renal hyscription factor)
poplasia and renal agenesis
have been observed in mice deficient for Pbx1
Protein phosphatase 3. Same as calci- The Pax3-CreT/þ; Cnb1flox/flox mice
(with calcineurin inactivation
neurin (serine/threonine protein
in the metanephric and
phosphatase)
ureteral mesenchyme): early
postnatal hydronephrosis
and hydroureter
Protein tyrosine phosphatase, receptor Ptprs; Ptprf double-mutant have
type S & F (protein tyrosine
hydronephrosis, hydroureter,
phosphatase)
duplex system and ureterocele
Retinoic acid receptor a/retinoic acid re- Rara/; Rarb2/ mice have hydroceptor b 2 (nuclear receptors)
nephrosis, hydroureter, vesicoureteral reflux
Same as Ren1 (enzyme in the renRenin/ mice: hydronephrosis, renin–angiotension system)
nal parenchymal atrophy
Heat-shock protein 4 like
(chaperone?)

Ret proto-oncogene (receptor tyrosine kinase, receptor for Gdnf)

Likely mechanism

References

Unclear

[90]

UPJ development

[91]

Likely autoanitibodies against urinary tract components
Unclear

[92]

Abnormal UB elongation and
branching. Reduction of
expression
Ectopic UB

[93]

[94]

[26]

Ureter differentiation.
Mesonephros defects in WD
growth

[95–97]

Ectopic and supernumerary UB

[98]

Aberrant proliferation and apoptosis of UB cells
Abnormal development of the UPJ
and UVJ

[99]

Establish of MM from intermediate
mesoderm
Delay in urinary tract maturation
in the Pax21Neu/þ mice

[101–103]

[100]

[104–111]

MM dysfunction

[112]

Pyeloureteral peristaltic defect, defect in urinary tract SMC
development

[113]

Defects in ureter maturation

[114]

Defective differentiation of the MM [115]

Possibly by polyuria. It is also possible that the mutation disrupts
SM differentiation
Ret/ mice: renal agenesis, defec- UB initiation defect, distal WD
tive WD insertion into the cloaca
growth

[116]

[117–119]

(continued)
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Table 2. (continued)
Gene/allele
symbols

Gene names and functions

Roundabout homolog 2 (SLIT2
receptor)

SALL1/Sall1

SAL-like 1 (transcription factor)

SIX1/Six1

SIX homeobox 1 (transcription
factor)

SIX2/Six2

SIX homeobox 2 (transcription
factor)

Shh

Sonic hedgehog (secreted signaling
molecule)

Slc12a1

Solute carrier family 12, member 1.
Same as Nkcc2 – (sodium–potassium–chloride cotransporter)
Slit homolog 2 (ROBO2 ligand)

Slit2
Smad4

MAD homolog 4 (TGF-b signal
transducer)

Spry1

Sprouty homolog 1 (RTK/ERK
antagonist)
Sprouty homolog 2 (RTK/ERK
antagonist)
T-box transcription factor 18 (transcription factor)

Spry2
Tbx18

Tensin

Tshz3
UpkII

UpkIIIA

Wnt4

Mice carrying Ret alleles with specific mutation of the key tyrosines: CAKUT (hydronephrosis,
hydroureter, vesicoureteral reflux, dysplasia, hypoplasia, duplication, agenesis)
Mice overexpressing Ret in UB: vesicoureteral reflux
Robo2/ mice carrying ROBO2
mutations/variants have vesicoureteral reflux
Heterozygous mutations in SALL1
in cause Townes-Brocks syndrome with renal involvement.
Mice deficient for Sall1 have renal agenesis or severe
dysgenesis
SIX1 mutations cause certain types
of bronchio-oto-renal syndrome.
Mice deficient for Six1 lack
kidneys
Mice deficient for Six2 have severe
renal hypoplasia

Hoxb7-CreT/þ; Shhflox/flox mice (Shh/

in UB derivatives): hydroureter
and hydronephrosis
Nkcc2/ mice: polyuria and hydronephrosis of varying severity
Slit2/ mice: hydroureter and
hydronephrosis
Bmp7-CreT/þ; Smad4flox/flox mice:
hydronephrosis
Tbx18-CreT/þ; Smad4flox/flox mice:
UPJO, hydroureter
Spry1/ mice: hydroureter and
hydronephrosis
Spry2/ mice: renal agenesis,
hydroureter and hydronephrosis
Tbx18/ mice: hydronephrosis,
hydroureter and short ureters

Likely mechanism

[13, 73, 120–
123, 124]

Ureter maturation defect

[125]

Ectopic and supernumerary UB

[126–128]

Disruption of UB initiation

[129–131]

Failure of UB invasion into MM

[132, 133]

Premature and ectopic differentiation of mesenchymal cells into
epithelia; depletion of the progenitor cell population within
the MM
Mesenchymal proliferation, SMC
differentiation

[43, 134, 135]

Possibly by polyuria overwhelming
the pyeloureteral peristaltic
machinery
Ectopic and supernumerary UB

[137]

[126]

Defective MM differentiation

[138, 139]

Ectopic and supernumerary UB

[140]

Ectopic and supernumerary UB

[141]

[136]

Ureteral SM defects due to ureteric [142]
mesenchyme differentiation
anomalies
Unclear. May involve cell–cell, cell– [143]
matrix interaction

Tensin/ mice: cystic and hydronephrotic kidney at a few
months of age
Teashirt zinc finger family member 3
Tshz3/ mice: hydronephrosis and Defects in ureteral SM
(transcription factor)
hydronephrosis
differentiation
Urothelial hyperplasia may block
Uroplakin II (glycolsylated transUpkII/ mice: hydronephrosis,
hydroureter, vesicoureteral
the urinary path. Alternatively,
membrane protein)
reflux
the urothelium defects may affect SM development
Urothelial hyperplasia may block
Uroplakin III (glycolsylated transUpkIII/ mice: hydronephrosis,
the urinary path. Alternatively,
hydroureter, vesicoureteral
membrane protein)
the urothelium defects may afreflux
fect SM development
Wingless-type MMTV integration site Mice deficient for Wnt4 have renal Failure in mesenchymal to epithefamily, member 4 (secreted signalagenesis and hypoplasia
lial transition
ing protein)
Same as Tns1 (actin-binding
protein)

References

Cell survival, proliferation, migration Wolffian duct patterning,
UB induction, ureteral
maturation

[144]
[115]

[145]

[146, 147]

(continued)
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Table 2. (continued)
Gene/allele
symbols
Wnt9b

Wingless-type MMTV integration site
family, member 9b (secreted signaling protein)
Wingless-type MMTV integration site
family, member 11 (secreted signaling protein)

Defects in human patients and animal models

Likely mechanism

References

Mice deficient for Wnt9b have renal Defective early inductive response
agenesis and hypoplasia
in MM

[148]

Mice deficient for Wnt9b have renal Defects in branching
hypoplasia
morphogenesis

[149]

There are many more genes than those listed involved in congenital anomalies of the kidney and urinary tract. The information presented in this table is not meant to
be complete but is an example of genes known to be involved in various types of kidney and urinary tract anomalies. We apologize to the many researchers whose
work is not cited in this table due to space constraints. SMC, smooth muscle cells; BMP, Bone morphogenetic protein; YAC, yeast artificial chromosome.

Table 3. Human gene mutations, associated syndromic and nonsyndromic CAKUT and potential developmental processes contributing to the
phenotype
CAKUT phenotype
Agenesis

Developmental process affected

Genes and genetic mechanism

Ectopic ureters, duplex collecting
system, dysplasia
Agenesis, hypoplasia

Wolffian duct growth, pre-UB
development
Maintaining single UB

Autosomal dominant: LIM1, PAX2, PAX8, GATA3, EYA1, FOXC1, RET [5, 7, 8, 25,
150–157]
Autosomal dominant: RET, GDNF, ROBO2, LIM1, GATA3, EYA1, BMP4 [5, 7, 8, 25,
150–152, 154, 155]

UB induction

Hypoplasia,
dysplasia

Branching morphogenesis,
nephrogenesis

Ureter defects (vesicoureteral reflux,
UPJO, ureterocele)

Ureter maturation, Wolffian duct–
cloaca fusion

Autosomal dominant: RET, GDNF, SALL1, SIX1 [5, 7, 8, 25, 150–152, 154]
Autosomal recessive: ITGA8 [158]
Autosomal dominant: RET, WT1, PAX2, GDNF, BMP7, SALL1, HNF1B, MKS1, MKS2,
BMP4, GLI3, SIX2, DHCR7, SIX1, SIX5, MYOG, DSTYK, WNT4, SOX17, UPK3A [5, 7, 8,
25, 150–157]
Autosomal recessive: FRAS1, FREM1, FREM2, ITGA8, AGT, AGTR1 [5, 7, 8, 25, 150–152]
Genomic disorders: 4P deletion, rare CNVs (16p13, 17q12, 22q11 and others) [159–
161]
X-linked: KAL1, GPC3 [5, 7, 8, 25, 150–152]
Autosomal dominant: RET, GREM1, EYA1, ROBO2, PAX2, UPK3A, NF1A, AT [5, 7, 8,
25, 150–157]
Genomic disorders: rare CNVs [159–161]
X-linked: AGTR2 [24, 35]

or even asymmetrically to one side of the body. The fusion may
also affect rotation of the kidney. These changes can lead to tortuous ureters, predisposing to urinary tract obstruction and subsequent kidney damage. Major subtypes of positional
anomalies include the following.
Horseshoe kidneys. Horseshoe kidneys are the most common
fusion abnormality (1/400), resulting from abnormal positioning
of the mesenchyme or the WDs. The fusion tends to affect the
normal ascent of the kidneys to the upper abdomen. The kidney
parenchyma may be histologically normal unless affected by reflux or obstruction during development.
Crossed fused renal ectopia. In this second most common position anomaly (1/2000), the kidney has crossed the midline and
fused with the contralateral kidney. The crossed kidney is usually smaller compared with the orthotopic kidney.
Ectopia. Ectopic kidneys are not located in the renal fossa.
Ectopia can be simple (ipsilateral to the pelvis) or crossed (contralateral to the ureter entry site into the bladder) [175]. This
could be due to defects in ascent or an abnormal UB budding
site. The incidence of simple ectopia in clinical settings is 1/
10 000, but it is much higher in autopsies (1/1000). Solitary

crossed renal ectopia is much rarer (1/1 500 000) and the ureter
crosses over and lies contralateral to its entry site into the bladder. Ectopia and fusion defects may coexist, such as in pelvic
horseshoe kidneys.
Malrotation. Malrotated kidneys are abnormally rotated along
their long axis. These could be due to a failure of medial rotation
during ascent. As a result, the hilum is often facing anteriorly.
The incidence rate is 1/500. Malrotated kidneys usually do not
cause any symptoms unless accompanied by other anomalies.

Hydronephrosis
Hydronephrosis is distension and dilatation of the renal pelvis
and calyces, usually caused by interruption of the free flow of
urine away from the kidney. Lower urinary tract defects may
block the urinary path or affect pyeloureteral peristalsis for effective urine transport, leading to hydronephrosis [176]. Defects
within the kidney, such as urine concentration problems, can
lead to severe polyuria that overwhelms the pyeloureteral peristalsis, leading to eventual disruption of urinary flow.
Cystinuria can lead to kidney stones, which can both block
urine outflow and affect ureteral peristalsis, leading to obstruction [177–179]. Thus hydronephrosis is the outcome of direct
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nephropathy, ESRD and mortality, especially when obstruction
is bilateral.

Ureteropelvic junction obstruction

FIGURE 4: VCUG depicts complete duplication of the urinary system. The primary ureter (ureter1) inserts higher in the bladder and drains the lower kidney
(kidney1). The dilated ureter2 inserts much lower in the bladder and drains the
upper kidney (kidney2). Duplication can arise from failure to repress ectopic
budding from the Wolffian duct or multiple UB inductions during metanephros
development.

and indirect effects of conditions affecting the urinary conduit
and is not a distinct disease entity by itself.

Obstructive nephropathy and obstructive uropathy
Persistence of hydronephrosis can result in tubular atrophy, inflammation and fibrosis (Figure 6) [180–182]. These pathological
changes are collectively referred to as ‘obstructive nephropathy’
and ‘obstructive uropathy’. These terms have similar meanings,
with slight emphasis on pathological changes within the kidney
(obstructive nephropathy) or with additional reference to involvement of the lower urinary tract (obstructive uropathy).
Damage to kidney architecture and function by urinary tract obstruction is especially devastating to the developing kidneys.
Even mild prenatal urinary tract obstruction can greatly affect
the number of nephrons formed. Severe prenatal urinary tract
obstruction can lead to the arrest of kidney development and
total loss of its function. In fact, congenital obstructive nephropathy is the most common cause of chronic kidney diseases in
the pediatric population. Elevated hydrostatic pressure associated with obstruction results in radial dilatation of the tubules
and ducts, leading to increased epithelial apoptosis and tubular
atrophy, and causes a reduction in the glomerular filtration
rate. Infiltration of immune cells has been frequently reported
as obstructive nephropathy progresses. Disruption of the renal
architecture usually correlates with the increased severity of fibrosis [183–185]. Complete obstruction of the urinary tract is relatively rare, but when it happens, timely intervention to release
the obstruction is critical for preserving kidney function. Partial
obstruction is more common in the clinical setting and even
partial obstruction can lead to progressive obstructive

Vesicoureteral reflux
Vesicoureteral reflux (VUR) is the retrograde flow of urine from
the bladder to the ureter [188]. VUR is generally diagnosed by
the retrograde flow of radioopaque contrast material during a
voiding cystourethrogram (VCUG) (Figure 8) [189, 190]. VUR has
been observed in 0.1–1% of children [191–193]. This may be
underestimated due to limited use of the invasive VCUG [194].
Although many patients with VUR show no kidney injury, other
VUR patients develop RN, with pathological changes in advanced stages similar to obstructive nephropathy. As much as
8% of ESRD may be caused by VUR [188]. The pathophysiology of
RN may be different than obstructive nephropathy, and early
stages show segmental scarring of the renal parenchyma due to
the propensity of reflux to damage superior and inferior lobes of
the kidney. This is because these regions have compound papillae with a round orifice that facilitates retrograde flow. If
untreated, the adjacent simple papillae transform into compound papillae and gradually affect the entire kidney. The
scarred regions show thinning of the overlying cortex. If VUR is
the only urinary tract anomaly found, then it is referred to as
primary VUR. VUR is often associated with, and likely secondary
to, other types of urinary tract defects, such as neurogenic bladder, posterior urethral valves (PUV) or ureterocele [195–197].
VUR can also occur as part of extrarenal syndromes [194]. VUR
is frequently associated with urinary tract infection (UTI). UTIs
in the setting of VUR may affect kidney function by providing
access to bacteria from the bladder into the ureter and kidney
and causing scarring (RN). By VCUG, 25–40% of screened children with UTI have VUR [198].

Ureterovesical junction obstruction and hydroureter
The ureterovesical junction (UVJ) is the site where the ureter
enters the bladder. Back pressure associated with physical obstruction at the UVJ usually causes dilatation of the ureter
(hydroureter or megaureter) and eventually hydronephrosis.
Although less common than UPJO, persistent UVJ obstruction
(UVJO) is as damaging to kidney function as UPJO. UVJO can be
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Ureteropelvic junction obstruction (UPJO) is the junction between the kidney pelvis and the ureters. UPJO is defined as an
obstruction of urine flow through the UPJ, causing progressive
renal damage (Figure 7) [186, 187]. UPJ is a location where progenitor cells of different embryonic origins coalesce to form the
ureter muscular layer. Due to its anatomical position and the
complexity of the integration of separate progenitor cell populations, UPJO accounts for 50% of all antenatal hydronephrosis
cases and is the most common cause of congenital obstructive
nephropathy [186, 187]. Approximately, 1/100 pregnancies show
fetal upper urinary tract dilation by ultrasound. Although most
of these dilatations resolve spontaneously, 1/500 remains clinically significant. UPJO occurs far more frequently in males than
in females (3–4:1) and more frequently on the left side. Crossing
blood vessels in some patients can also cause UPJO. Currently
surgical intervention remains the only option for UPJO due to
intrinsic causes. In children, the procedure of choice is an
Anderson–Hynes dismembered pyeloplasty in which the
obstructed segment is resected and the remaining ureter is
reanastomosed.
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into cortex, medulla and papillae. Numerous cysts are scattered in the kidney. The image on the left highlights collecting ducts in the center surrounded by concentric
immature mesenchymal cells (arrows). The image on the right additionally has cartilage (white arrow) in the center that can be seen in about a third of dysplastic kidneys. Dysplasia can arise from abnormal UB budding or branching morphogenesis and nephrogenesis.

caused by a poorly peristalsing ureteral segment near the bladder, abnormal insertion of the ureter into the bladder, a short
intravesical ureteral segment, infection, scar tissues, kidney
stones and other factors. If an obstructed segment or anatomic
ureteral anomalies are present, then resection of the affected
segment and refitting the ureter into the bladder is the current
treatment option.

Ureterocele, ectopic ureter and duplicated ureter

FIGURE 6: Obstructive nephropathy. Hematoxylin and eosin–stained section of a
kidney from a patient with long-standing urinary tract obstruction shows significant kidney damage. Note that several tubules are dilated with no epithelial lining,
thus showing atrophy (arrows). A number of the tubules show proteinaceous eosinophilic material representative of end-stage nephrons. Also note the intense inflammatory infiltrate involving almost the entire parenchyma.

Ureterocele is a saccular dilation of the terminal portion of the
ureter inside the bladder (Figure 9) [176, 199]. The clinical effects
of ureteroceles range from being asymptomatic to causing urinary tract obstruction and kidney damage. The normal site of
ureter entry into the bladder is near the base of the bladder. The
bladder trigone (a thickened muscular pad on the back of the
bladder) helps to secure the intravesical segment of the ureter
to prevent kinking and reflux. An abnormal ureter entry site
and angle tend to nullify the function of the trigone, leading to
reflux or obstruction. In rare cases, the distal ureter connects to
the reproductive organs, such as the uterus, the vagina or the
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fuse dilation of the collecting system with dilated pelvis (arrow) due to lower
urinary tract obstruction. Obstruction can result from functional or physical abnormalities that are intrinsic or extrinsic to the urinary system.

FIGURE 9: Ureterocele. The lower abdominal and pelvic ultrasonograph shows a
ureterocele (arrow). Note the clear blind ending ureterocele lining (arrow) connected to the dilated ureter (long hypoechogenic tube).

FIGURE 8: Vesicoureteral reflux (VUR). Vesicoureterocystogram shows highgrade (Grade 5) VUR. Note the dilated, tortuous ureter, with reflux involving the
kidney parenchyma, highlighted by the white dye almost spanning each kidney.
Primary VUR is due to abnormal development of the ureterovesicle junction so
that the valve mechanism to prevent reflux from the bladder into the ureter
does not function normally.

epididymis [200–203]. The resulting fistulae between the ureter
and the reproductive organs tend to be obstructed, leading to
hydroureter, hydronephrosis and kidney damage.

Bladder outlet obstruction and posterior urethral valves

FIGURE 10: Posterior uretheral valves (PUV). The radiograph shows classic findings of PUV in a male child. Note the extreme narrowing of the urethra (arrow)

Bladder outlet obstruction is the blockage of urine passage from
the bladder to the urethra caused by benign prostate hyperplasia, bladder tumor, bladder stones, PUV or other causes. PUV, a
congenital blockage of the posterior urethra [204, 205], is a common cause of urinary tract obstruction in male infants, with an
estimated incidence rate of 1/5000–8000 male births and may
account for 10% of all prenatally detected hydronephrosis [206–
208]. PUVs can cause bilateral kidney damage, kidney failure
and even death. It is one of the leading causes of kidney failure

due to persistent valves that lead to a dilated bladder with irregular surface
(trabeculations).

in children. PUV is typically detected by prenatal ultrasound
and subsequently diagnosed definitively after birth. Fetuses
with PUV can have bilateral hydroureter/hydronephrosis with a
thick trabeculated bladder wall and keyhole sign in the bladder
neck (Figure 10). A VCUG and/or cystoscopic evaluation can be
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used to demonstrate the presence of the ‘valves’ or ‘membranes’ that block urine passage. Although a bladder catheter
can provide immediate relief, endoscopic ablation can be performed to permanently correct the defects.

6.
7.

A prominent feature of the development of the urinary system
is the dynamic temporal and spatial integration of progenitor
tissues of distinct embryonic origins. Such integration requires
precise control of proliferation, apoptosis, migration and differentiation of all the progenitor cells involved to create junctional
complexes, which if malformed result in bottlenecks for urine
passage [9]. Research in animal models, especially transgenic
mouse models, has contributed to a better understanding of the
genetic factors and mechanisms of the pathogenesis of CAKUT
(Table 2) that help us understand the genotype–phenotype association and mechanism in CAKUT patients (Table 3). Of note,
many CAKUT cases have a developmental basis even before the
metanephric kidney begins to develop. A deeper understanding
of the embryonic processes underlying normal and abnormal
development of the urinary tract will inform potential targetable therapies with small molecules and provide necessary
knowledge to build kidneys that can be transplanted into
patients. Genetic studies have taught us that CAKUT is a genetically heterogeneous disorder and the phenotype is influenced
by gene interactions and epigenetic pathways. A major challenge in patient care is determining the pathogenicity of potentially deleterious variants identified in patients. Advances in
the field of genome editing and induced pluripotent cell-derived
kidney organoids will surely overcome this hurdle in the near
future and ultimately bring precision medicine to patients with
CAKUT.

8.

9.
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Michos O, Gonçalves A, Lopez-Rios J et al. Reduction of
BMP4 activity by gremlin 1 enables ureteric bud outgrowth
and GDNF/WNT11 feedback signalling during kidney
branching morphogenesis. Development 2007; 134:
2397–2405
Bingham C, Ellard S, Cole TRP et al. Solitary functioning kidney and diverse genital tract malformations associated
with hepatocyte nuclear factor-1b mutations. Kidney Int
2002; 61: 1243–1251
Bingham C, Bulman MP, Ellard S et al. Mutations in the hepatocyte nuclear factor-1b gene are associated with familial hypoplastic glomerulocystic kidney disease. Am J Hum
Genet 2001; 68: 219–224
Bingham C, Ellard S, Allen L et al. Abnormal nephron development associated with a frameshift mutation in the transcription factor hepatocyte nuclear factor-1 b. Kidney Int
2000; 57: 898–907
Lindner TH, Njolstad PR, Horikawa Y et al. A novel syndrome of diabetes mellitus, renal dysfunction and genital
malformation associated with a partial deletion of the
pseudo-POU domain of hepatocyte nuclear factor-1b. Hum
Mol Genet 1999; 8: 2001–2008
Kolatsi-Joannou M, Bingham C, Ellard S. Hepatocyte nuclear factor-1b: a new kindred with renal cysts and diabetes
and gene expression in normal human development. J Am
Soc Nephrol 2001; 12: 2175–2180

83.

Lokmane L, Heliot C, Garcia-Villalba P et al. vHNF1 functions in distinct regulatory circuits to control ureteric bud
branching and early nephrogenesis. Development 2010; 137:
347–357
84. Wellik DM, Hawkes PJ, Capecchi MR. Hox11 paralogous
genes are essential for metanephric kidney induction.
Genes Dev 2002; 16: 1423–1432
85. Patterson LT, Pembaur M, Potter SS. Hoxa11 and Hoxd11
regulate branching morphogenesis of the ureteric bud in
the developing kidney. Development 2001; 128: 2153–2161
86. Mugford JW, Sipila P, Kobayashi A et al. Hoxd11 specifies a
program of metanephric kidney development within the
intermediate mesoderm of the mouse embryo. Dev Biol
2008; 319: 396–405
87. Warot X, Fromental-Ramain C, Fraulob V et al. Gene
dosage-dependent effects of the Hoxa-13 and Hoxd-13
mutations on morphogenesis of the terminal parts of the
digestive and urogenital tracts. Development 1997; 124:
4781–4791
88. Daly SB, Urquhart JE, Hilton E et al. Mutations in
HPSE2 cause urofacial syndrome. Am J Hum Genet 2010; 86:
963–969
89. Guo C, Kaneko S, Sun Y et al. A mouse model of urofacial
syndrome with dysfunctional urination. Hum Mol Genet
2015; 24: 1991–1999
90. Held T, Paprotta I, Khulan J et al. Hspa4l-deficient mice display increased incidence of male infertility and hydronephrosis development. Mol Cell Biol 2006; 26: 8099–8108
91. Aoki Y, Mori S, Kitajima K et al. Id2 haploinsufficiency in
mice leads to congenital hydronephrosis resembling that
in humans. Genes Cells 2004; 9: 1287–1296
92. Lauder AJ, Jolin HE, Smith P et al. Lymphomagenesis, hydronephrosis, and autoantibodies result from dysregulation of
IL-9 and are differentially dependent on Th2 cytokines.
J Immunol 2004; 173: 113–122
93. Lorenz JN, Baird NR, Judd LM et al. Impaired renal NaCl absorption in mice lacking the ROMK potassium channel, a
model for type II Bartter’s syndrome. J Biol Chem 2002; 277:
37871–37880
94. Kaku Y, Ohmori T, Kudo K et al. Islet1 deletion causes kidney agenesis and hydroureter resembling CAKUT. J Am Soc
Nephrol 2013; 24: 1242–1249
95. Shawlot W, Behringer RR. Requirement for Lim1 in headorganizer function. Nature 1995; 374: 425–430
96. Tsang TE, Shawlot W, Kinder SJ et al. Lim1 activity is required for intermediate mesoderm differentiation in the
mouse embryo. Dev Biol 2000; 223: 77–90
97. Kobayashi A, Kwan KM, Carroll TJ et al. Distinct and sequential tissue-specific activities of the LIM-class homeobox gene Lim1 for tubular morphogenesis during kidney
development. Development 2005; 132: 2809–2823
98. Gamp AC, Tanaka Y, Lullmann-Rauch R. LIMP-2/LGP85 deficiency causes ureteric pelvic junction obstruction, deafness
and peripheral neuropathy in mice. Hum Mol Genet 2003; 12:
631–646
99. Hilliard S, Aboudehen K, Yao X et al. Tight regulation of p53
activity by Mdm2 is required for ureteric bud growth and
branching. Dev Biol 2011; 353: 354–366
100. Lu W, Quintero-Rivera F, Fan Y et al. NFIA haploinsufficiency is associated with a CNS malformation syndrome
and urinary tract defects. PLoS Genet 2007; 3: e80
101. Mugford JW, Sipila P, McMahon JA et al. Osr1 expression
demarcates a multi-potent population of intermediate

Downloaded from https://academic.oup.com/ckj/article-abstract/12/3/382/5224972 by Washington University, Law School Library user on 15 November 2019

67.

|

Developmental pathology CAKUT

102.

104.

105.

106.

107.

108.

109.

110.

111.

112.

113.

114.

115.

116.

117.

118.

397

119. Batourina E, Choi C, Paragas N et al. Distal ureter morphogenesis depends on epithelial cell remodeling mediated by
vitamin A and Ret. Nat Genet 2002; 32: 109–115
120. Jain S, Encinas M, Johnson EM Jr et al. Critical and distinct
roles for key RET tyrosine docking sites in renal development. Genes Dev 2006; 20: 321–333
121. Jijiwa M, Fukuda T, Kawai K et al. A targeting mutation of tyrosine 1062 in Ret causes a marked decrease of enteric neurons and renal hypoplasia. Mol Cell Biol 2004; 24: 8026–8036
122. Skinner MA, Safford SD, Reeves JG et al. Renal aplasia in
humans is associated with RET mutations. Am J Hum Genet
2008; 82: 344–351
123. Zhang Z, Quinlan J, Hoy W et al. A common RET variant is
associated with reduced newborn kidney size and function.
J Am Soc Nephrol 2008; 19: 2027–2034
124. Hoshi M, Reginensi A, Joens MS et al. Reciprocal spatiotemporally controlled apoptosis regulates Wolffian duct cloaca
fusion. J Am Soc Nephrol 2018; 29: 775–783
125. Yu OH, Murawski IJ, Myburgh DB et al. Overexpression of
RET leads to vesicoureteric reflux in mice. Am J Physiol Renal
Physiol 2004; 287: F1123–F1130
126. Grieshammer U, Le M, Plump AS. SLIT2-mediated ROBO2
signaling restricts kidney induction to a single site. Dev Cell
2004; 6: 709–717
127. Lu W, van Eerde AM, Fan X et al. Disruption of ROBO2 is associated with urinary tract anomalies and confers risk of
vesicoureteral reflux. Am J Hum Genet 2007; 80: 616–632
128. Bertoli-Avella AM, Conte ML, Punzo F et al. ROBO2 gene variants are associated with familial vesicoureteral reflux.
J Am Soc Nephrol 2008; 19: 825–831
129. Kiefer SM, Ohlemiller KK, Yang J et al. Expression of a truncated Sall1 transcriptional repressor is responsible for
Townes-Brocks syndrome birth defects. Hum Mol Genet
2003; 12: 2221–2227
130. Nishinakamura R, Matsumoto Y, Nakao K et al. Murine homolog of SALL1 is essential for ureteric bud invasion in kidney development. Development 2001; 128: 3105–3115
131. Kohlhase J. SALL1 mutations in Townes-Brocks syndrome
and related disorders. Hum Mutat 2000; 16: 460–466
132. Ruf RG, Xu P-X, Silvius D et al. SIX1 mutations cause
branchio-oto-renal syndrome by disruption of EYA1-SIX1DNA complexes. Proc Natl Acad Sci USA 2004; 101: 8090–8095
133. Xu PX, Zheng W, Huang L et al. Six1 is required for the early
organogenesis of mammalian kidney. Development 2003;
130: 3085–3094
134. Kobayashi A, Valerius MT, Mugford JW et al. Six2 defines
and regulates a multipotent self-renewing nephron progenitor population throughout mammalian kidney development. Cell Stem Cell 2008; 3: 169–181
135. Self M, Lagutin OV, Bowling B et al. Six2 is required for suppression of nephrogenesis and progenitor renewal in the
developing kidney. EMBO J 2006; 25: 5214–5228
136. Yu J, Carroll TJ, McMahon AP. Sonic hedgehog regulates
proliferation and differentiation of mesenchymal cells in
the mouse metanephric kidney. Development 2002; 129:
5301–5312
137. Takahashi N, Chernavvsky DR, Gomez RA et al.
Uncompensated polyuria in a mouse model of Bartter’s
syndrome. Proc Natl Acad Sci USA 2000; 97: 5434–5439
138. Oxburgh L, Chu GC, Michael SK et al. TGFb superfamily signals are required for morphogenesis of the kidney mesenchyme progenitor population. Development 2004; 131:
4593–4605

Downloaded from https://academic.oup.com/ckj/article-abstract/12/3/382/5224972 by Washington University, Law School Library user on 15 November 2019

103.

mesoderm that undergoes progressive restriction to an
Osr1-dependent nephron progenitor compartment within
the mammalian kidney. Dev Biol 2008; 324: 88–98
James RG, Kamei CN, Wang Q et al. Odd-skipped related 1 is
required for development of the metanephric kidney and
regulates formation and differentiation of kidney precursor
cells. Development. 2006; 133: 2995–3004
Wang Q, Lan Y, Cho ES et al. Odd-skipped related 1 (Odd1) is
an essential regulator of heart and urogenital development.
Dev Biol 2005; 288: 582–594
Murawski IJ, Myburgh DB, Favor J et al. Vesico-ureteric reflux and urinary tract development in the Pax2 1Neuþ/
mouse. Am J Physiol Renal Physiol 2007; 293: F1736–F1745
Sanyanusin P, Schimmenti LA, McNoe LA et al. Mutation of
the PAX2 gene in a family with optic nerve colobomas, renal anomalies and vesicoureteral reflux. Nat Genet 1995; 9:
358–364
Choi KL, McNoe LA, French MC et al. Absence of PAX2 gene
mutations in patients with primary familial vesicoureteric
reflux. J Med Genet 1998; 35: 338–339
Favor J, Sandulache R, Neuhauser-Klaus A et al. The mouse
Pax2(1Neu) mutation is identical to a human PAX2 mutation in a family with renal-coloboma syndrome and results
in developmental defects of the brain, ear, eye, and kidney.
Proc Natl Acad Sci USA 1996; 93: 13870–13875
Sanyanusin P, McNoe LA, Sullivan MJ et al. Mutation of
PAX2 in two siblings with renal-coloboma syndrome. Hum
Mol Genet 1995; 4: 2183–2184
Keller SA, Jones JM, Boyle A. Kidney and retinal defects
(Krd), a transgene-induced mutation with a deletion of
mouse chromosome 19 that includes the Pax2 locus.
Genomics 1994; 23: 309–320
Dressler GR, Wilkinson JE, Rothenpieler UW et al.
Deregulation of Pax-2 expression in transgenic mice generates severe kidney abnormalities. Nature 1993; 362: 65–67
Torres M, Gomez-Pardo E, Dressler GR et al. Pax-2 controls
multiple steps of urogenital development. Development
1995; 121: 4057–4065
Schnabel CA, Godin RE, Cleary ML. Pbx1 regulates nephrogenesis and ureteric branching in the developing kidney.
Dev Biol 2003; 254: 262–276
Chang CP, McDill BW, Neilson JR et al. Calcineurin is required in urinary tract mesenchyme for the development
of the pyeloureteral peristaltic machinery. J Clin Invest 2004;
113: 1051–1058
Uetani N, Bertozzi K, Chagnon MJ et al. Maturation of
ureter-bladder connection in mice is controlled by LAR
family receptor protein tyrosine phosphatases. J Clin Invest
2009; 119: 924–935
Kong X-T, Deng F-M, Hu P et al. Roles of uroplakins in plaque formation, umbrella cell enlargement, and urinary
tract diseases. J Cell Biol 2004; 167: 1195–1204
Takahashi N, Lopez MLSS, Cowhig JE et al. Ren1c homozygous null mice are hypotensive and polyuric, but heterozygotes are indistinguishable from wild-type. J Am Soc Nephrol
2005; 16: 125–132
Vega QC, Worby CA, Lechner MS et al. Glial cell line-derived
neurotrophic factor activates the receptor tyrosine kinase
RET and promotes kidney morphogenesis. Proc Natl Acad Sci
USA 1996; 93: 10657–10661
Sainio K, Suvanto P, Davies J et al. Glial-cell-line-derived
neurotrophic factor is required for bud initiation from ureteric epithelium. Development 1997; 124: 4077–4087

|

398

|

S. Jain and F. Chen

159. Sanna-Cherchi S, Kiryluk K, Burgess KE et al. Copy-number
disorders are a common cause of congenital kidney malformations. Am J Hum Genet 2012; 91: 987–997
160. Verbitsky M, Sanna-Cherchi S, Fasel DA et al. Genomic
imbalances in pediatric patients with chronic kidney disease. J Clin Invest 2015; 125: 2171–2178
161. Westland R, Verbitsky M, Vukojevic K et al. Copy number
variation analysis identifies novel CAKUT candidate genes
in children with a solitary functioning kidney. Kidney Int
2015; 88: 1402–1410
162. Whitten SM, Wilcox DT. Duplex systems. Prenat Diagn 2001;
21: 952–957
163. N’Guessan G, Stephens FD. Supernumerary kidney. J Urol
1983; 130: 649–653
164. Haddad FS, Griffin EE. II The Weigert-Meyer law demystified. J Islamic Med Assoc 1996; 28: 16–19
165. Kerecuk L, Schreuder MF, Woolf AS. Renal tract malformations: perspectives for nephrologists. Nat Clin Pract Nephrol
2008; 4: 312–325
166. Potter EL. Facial characteristics of infants with bilateral renal agenesis. Am J Obstet Gynecol 1946; 51: 885–888
167. Winyard P, Chitty LS. Dysplastic kidneys. Semin Fetal
Neonatal Med 2008; 13: 142–151
168. Hiraoka M, Tsukahara H, Ohshima Y et al. Renal aplasia is
the predominant cause of congenital solitary kidneys.
Kidney Int 2002; 61: 1840–1844
169. Mansoor O, Chandar J, Rodriguez MM et al. Long-term risk
of chronic kidney disease in unilateral multicystic dysplastic kidney. Pediatr Nephrol 2011; 26: 597–603
170. Grattan-Smith JD, Jones RA, Little S et al. Bilateral congenital midureteric strictures associated with multicystic dysplastic kidney and hydronephrosis: evaluation with MR
urography. Pediatr Radiol 2011; 41: 117–120
171. Singh JK, Kanojia RP, Narasimhan KL. Multicystic dysplastic
kidney in children — a need for conservative and long term
approach. Indian J Pediatr 2009; 76: 809–812
172. Schreuder MF, Westland R, van Wijk JA. Unilateral multicystic dysplastic kidney: a meta-analysis of observational
studies on the incidence, associated urinary tract malformations and the contralateral kidney. Nephrol Dial
Transplant 2009; 24: 1810–1818
173. Kiyak A, Yilmaz A, Turhan P et al. Unilateral multicystic
dysplastic kidney: single-center experience. Pediatr Nephrol
2009; 24: 99–104
174. Hains DS, Bates CM, Ingraham S et al. Management and etiology of the unilateral multicystic dysplastic kidney: a review. Pediatr Nephrol 2009; 24: 233–241
175. van den Bosch CMA, van Wijk JAE, Beckers GMA et al.
Urological and nephrological findings of renal ectopia.
J Urol 2010; 183: 1574–1578
176. Stephens FD, Smith ED, Hutson JM. Congenital Anomalies of
the Kidney, Urinary and Genital Tracts: London: Martin Dunitz,
2002
177. Parvex P, Pippi-Salle JL, Goodyer PR. Rapid loss of renal parenchyma after acute obstruction. Pediatr Nephrol 2001; 16:
1076–1079
178. Ercolani M, Sahota A, Schuler C et al. Bladder outlet obstruction in male cystinuria mice. Int Urol Nephrol 2010; 42:
57–63
179. Gambaro G, Favaro S, D’Angelo A. Risk for renal failure in
nephrolithiasis. Am J Kidney Dis 2001; 37: 233–243
180. Chevalier RL, Thornhill BA, Forbes MS et al. Mechanisms of
renal injury and progression of renal disease in congenital
obstructive nephropathy. Pediatr Nephrol 2010; 25: 687–697

Downloaded from https://academic.oup.com/ckj/article-abstract/12/3/382/5224972 by Washington University, Law School Library user on 15 November 2019

139. Tripathi P, Wang Y, Casey AM, et al. Absence of canonical
Smad signaling in ureteral and bladder mesenchyme
causes ureteropelvic junction obstruction. J Am Soc Nephrol
2012; 23: 618–628
140. Basson MA, Akbulut S, Watson-Johnson J et al. Sprouty1 is a
critical regulator of GDNF/RET-mediated kidney induction.
Dev Cell 2005; 8: 229–239
141. Chi L, Zhang S, Lin Y et al. Sprouty proteins regulate ureteric
branching by coordinating reciprocal epithelial Wnt11,
mesenchymal Gdnf and stromal Fgf7 signalling during kidney development. Development 2004; 131: 3345–3356
142. Airik R, Bussen M, Singh MK et al. Tbx18 regulates the development of the ureteral mesenchyme. J Clin Invest 2006; 116:
663–674
143. Lo SH, Yu QC, Degenstein L et al. Progressive kidney degeneration in mice lacking tensin. J Cell Biol 1997; 136:
1349–1361
144. Caubit X, Lye CM, Martin E et al. Teashirt 3 is necessary for
ureteral smooth muscle differentiation downstream of
SHH and BMP4. Development 2008; 135: 3301–3310
145. Hu P, Deng F-M, Liang F-X et al. Ablation of uroplakin III
gene results in small urothelial plaques, urothelial leakage,
and vesicoureteral reflux. J Cell Biol 2000; 151: 961–972
146. Kispert A, Vainio S, McMahon AP. Wnt-4 is a mesenchymal
signal for epithelial transformation of metanephric mesenchyme in the developing kidney. Development 1998; 125:
4225–4234
147. Stark K, Vainio S, Vassileva G et al. Epithelial transformation of metanephric mesenchyme in the developing kidney
regulated by Wnt-4. Nature 1994; 372: 679–683
148. Carroll TJ, Park JS, Hayashi S et al. Wnt9b plays a central role
in the regulation of mesenchymal to epithelial transitions
underlying organogenesis of the mammalian urogenital
system. Dev Cell 2005; 9: 283–292
149. Majumdar A, Vainio S, Kispert A et al. Wnt11 and Ret/Gdnf
pathways cooperate in regulating ureteric branching during metanephric kidney development. Development 2003;
130: 3175–3185
150. Nicolaou N, Renkema KY, Bongers EM et al. Genetic, environmental, and epigenetic factors involved in CAKUT. Nat
Rev Nephrol 2015; 11: 720–731
151. Rodriguez MM. Congenital anomalies of the kidney and the
urinary tract (CAKUT). Fetal Pediatr Pathol 2014; 33: 293–320
152. Vivante A, Kohl S, Hwang DY et al. Single-gene causes of
congenital anomalies of the kidney and urinary tract
(CAKUT) in humans. Pediatr Nephrol 2014; 29: 695–704
153. Madariaga L, Morinière V, Jeanpierre C et al. Severe prenatal
renal anomalies associated with mutations in HNF1B or
PAX2 genes. Clin J Am Soc Nephrol 2013; 8: 1179–1187
154. Davis TK, Hoshi M, Jain S. To bud or not to bud: the RET perspective in CAKUT. Pediatr Nephrol 2014; 29: 597–608
155. Allison SJ. Basic research: Ret signaling reveals insights
into the pathogenesis of CAKUT. Nat Rev Nephrol 2012; 8:
432
156. Hwang D-Y, Dworschak GC, Kohl S et al. Mutations in 12
known dominant disease-causing genes clarify many congenital anomalies of the kidney and urinary tract. Kidney Int
2014; 85: 1429–1433
157. Harshman LA, Brophy PD. PAX2 in human kidney malformations and disease. Pediatr Nephrol 2012; 27: 1265–1275
158. Kohl S, Hwang D-Y, Dworschak GC et al. Mild recessive
mutations in six Fraser syndrome-related genes cause isolated congenital anomalies of the kidney and urinary tract.
J Am Soc Nephrol 2014; 25: 1917–1922

Developmental pathology CAKUT

399

195. Puri P, Kumar R. Endoscopic correction of vesicoureteral reflux secondary to posterior urethral valves. J Urol 1996; 156:
680–682
196. Hassan JM, Pope JC, Brock JW et al. Vesicoureteral reflux in
patients with posterior urethral valves. J Urol 2003; 170:
1677–1680
197. Upadhyay J, Bolduc S, Braga L et al. Impact of prenatal diagnosis on the morbidity associated with ureterocele management. J Urol 2002; 167: 2560–2565
198. Tullus K. Vesicoureteric reflux in children. Lancet 2015; 385:
371–379
199. Coplen DE, Duckett JW. The modern approach to ureteroceles. J Urol 1995; 153: 166–171
200. Avritscher R, Madoff DC, Ramirez PT et al. Fistulas of the
lower urinary tract: percutaneous approaches for the management of a difficult clinical entity. Radiographics 2004; 24:
S217–S236
201. Yu NC, Raman SS, Patel M et al. Fistulas of the genitourinary tract: a radiologic review. Radiographics 2004; 24:
1331–1352
202. Baird DR, Orangio GR, Lucas GW. A complex ileovaginal fistula with associated obstructive uropathy in a patient with
Crohn’s disease: technical considerations and review of the
literature. South Med J 1991; 84: 389–391
203. Dwyer PL, Rosamilia A. Congenital urogenital anomalies
that are associated with the persistence of Gartner’s duct: a
review. Am J Obstet Gynecol 2006; 195: 354–359
204. Krishnan A, de Souza A, Konijeti R et al. The anatomy and
embryology of posterior urethral valves. J Urol 2006; 175:
1214–1220
205. Hodges SJ, Patel B, McLorie G et al. Posterior urethral valves.
ScientificWorldJournal 2009; 9: 1119–1126
206. Lopez Pereira P, Martinez Urrutia MJ, Jaureguizar E. Initial
and long-term management of posterior urethral valves.
World J Urol 2004; 22: 418–424
207. Yohannes P, Hanna M. Current trends in the management
of posterior urethral valves in the pediatric population.
Urology 2002; 60: 947–953
208. Agarwal S. Urethral valves. BJU Int 1999; 84: 570–578

Downloaded from https://academic.oup.com/ckj/article-abstract/12/3/382/5224972 by Washington University, Law School Library user on 15 November 2019

181. Ingraham SE, McHugh KM. Current perspectives on congenital obstructive nephropathy. Pediatr Nephrol 2011; 26:
1453–1461
182. Liapis H. Biology of congenital obstructive nephropathy.
Nephron Exp Nephrol 2003; 93: e87–e91
183. Duffield JS. Epithelial to mesenchymal transition in injury
of solid organs: fact or artifact? Gastroenterology 2010; 139:
1081–1083
184. Humphreys BD, Lin SL, Kobayashi A et al. Fate tracing
reveals the pericyte and not epithelial origin of myofibroblasts in kidney fibrosis. Am J Pathol 2010; 176: 85–97
185. LeBleu VS, Taduri G, O’Connell J et al. Origin and function of
myofibroblasts in kidney fibrosis. Nat Med 2013; 19:
1047–1053
186. Klein J, Gonzalez J, Miravete M et al. Congenital ureteropelvic junction obstruction: human disease and animal models. Int J Exp Pathol 2011; 92: 168–192
187. Yiee JH, Johnson-Welch S, Baker LA et al. Histologic differences between extrinsic and intrinsic ureteropelvic junction obstruction. Urology 2010; 76: 181–184
188. Murawski IJ, Gupta IR. Vesicoureteric reflux and renal malformations: a developmental problem. Clin Genet 2006; 69:
105–117
189. Hensle TW, Grogg AL. Part 1: vesicoureteral reflux treatment: the past, present, and future. Curr Med Res Opin 2007;
23: S1–S5
190. Gargollo PC, Diamond DA. Therapy insight: what nephrologists need to know about primary vesicoureteral reflux. Nat
Clin Pract Nephrol 2007; 3: 551–563
191. Eccles MR, Jacobs GH. The genetics of primary vesicoureteric reflux. Ann Acad Med 2000; 29: 337–345
192. Mak RH, Kuo HJ. Primary ureteral reflux: emerging insights
from molecular and genetic studies. Curr Opin Pediatr 2003;
15: 181–185
193. Lama G, Russo M, De Rosa E et al. Primary vesicoureteric reflux and renal damage in the first year of life. Pediatr Nephrol
2000; 15: 205–210
194. Williams G, Fletcher JT, Alexander SI et al. Vesicoureteral
reflux. J Am Soc Nephrol 2008; 19: 847–862

|

